Key Highlights

  • Revenue rose 11.8% to USD 695.5 million, against an estimate of USD 679.48 million.
  • Adjusted EBITDA was USD 100.1 million, a 25% increase over the prior year.
  • Full-year guidance is above USD 2.695 billion Revenue and USD 374 million adjusted EBITDA.
  • Consolidated gross Margin was USD 226.8 million, or 32.6% of revenue.

Aveanna Healthcare (NASDAQ:AVAH) reported third-quarter 2026 revenue of USD 695.5 million, up 11.8% from the prior-year period and above the estimate of USD 679.48 million. Earnings Per Share were USD 0.23, against an estimate of USD 0.21. The company provides home-based care services across three operating segments.

Adjusted EBITDA was USD 100.1 million, a 25% increase over the prior-year period. Management attributed the increase mainly to the improved rate and Volume environment and continued operational efficiencies. Consolidated gross margin was USD 226.8 million, or 32.6% of revenue.

Segment Revenue and Cost Lines

Private Duty Services revenue was approximately USD 574 million for the quarter, an 11.6% increase. Management said results reflected execution across all three Business segments and progress on its 2026 strategic initiatives, including the Family First integration.

Branch and regional administrative expenses were USD 103.5 million, or 14.9% of revenue, for the three-month period ended October 3, 2026. That compares with USD 95.4 million, or 15.3% of revenue, in the prior-year quarter, an increase of USD 8.1 million, or 8.5%.

For the nine-month period, branch and regional administrative expenses were USD 296.3 million, or 14.7% of revenue, against USD 276.9 million, or 15.6%, a year earlier. The filing reports consolidated revenue up USD 243.2 million, or 13.7%, for the nine months, and a field contribution margin of 17.6%, against 18.1% a year earlier. Gross margin percentage for the nine months was 32.3%, against 33.7%.

Days sales outstanding were 43.9 at October 3, 2026, against 46.0 at September 27, 2025, according to the filing's five-quarter table. Net cash used in investing activities was USD 188.7 million for the nine-month period, compared with USD 20.3 million a year earlier.

On reimbursement, management said the California Department of Health Care Services has validated that the 2027 state budget includes a hard dollar Investment for private duty nursing rates of approximately USD 30 million. Management said that amount is matched by the federal government at a 50% rate, for a total investment of USD 60 million. The company described it as a supplemental payment for the budget period of January 1, 2027, through June 30, 2027.

Guidance and Long-term Growth Rates

The company increased its full-year 2026 guidance to revenue of more tha USD 2.695 billion and adjusted EBITDA of more tha USD 374 million. Management said the revised figures reflect the underlying business and Demand for its services.

Management also reconfirmed its long-term core organic growth rates across all three operating segments. It said it had communicated in the second quarter an adjustment to the long-term organic growth rate for private duty services, from 3% to 5% to 5% to 6%. It tied that change to improved state government affairs and continued execution with preferred payers.

Reported Reference Points for the Quarter

The reported items are revenue of USD 695.5 million, adjusted EBITDA of USD 100.1 million, gross margin of USD 226.8 million and the raised full-year guidance. Management described the labor environment as the primary challenge the company needed to address in order to resume its growth trajectory.

The quarterly filing was prepared for the period ended October 3, 2026, a 13-week fiscal quarter, and the company is listed on the Nasdaq Stock Market.